Basic Information
| LncRNA/CircRNA Name | FENDRR |
| Synonyms | NA |
| Region | GRCh38_16:86474529-86509099 |
| Ensemble | ENSG00000268388 |
| Refseq | NR_033925 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Luciferase reporter assay |
| Sample | NSCLC tissues,cell lines(A549,H1975) |
| Expression Pattern | down-regulated |
| Function Description | FENDRR is downregulated in NSCLC and inversely associated with prognosis. |
| Pubmed ID | 31545237 |
| Year | 2019 |
| Title | LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis. |
External Links
| Links for FENDRR | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |